1. Home
  2. MRNA vs MRO Comparison

MRNA vs MRO Comparison

Compare MRNA & MRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • MRO
  • Stock Information
  • Founded
  • MRNA 2010
  • MRO 1887
  • Country
  • MRNA United States
  • MRO United States
  • Employees
  • MRNA N/A
  • MRO N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • MRO Oil & Gas Production
  • Sector
  • MRNA Health Care
  • MRO Energy
  • Exchange
  • MRNA Nasdaq
  • MRO Nasdaq
  • Market Cap
  • MRNA 16.5B
  • MRO 16.0B
  • IPO Year
  • MRNA 2018
  • MRO N/A
  • Fundamental
  • Price
  • MRNA $36.85
  • MRO $28.59
  • Analyst Decision
  • MRNA Hold
  • MRO Buy
  • Analyst Count
  • MRNA 17
  • MRO 17
  • Target Price
  • MRNA $87.67
  • MRO $31.12
  • AVG Volume (30 Days)
  • MRNA 8.4M
  • MRO 5.7M
  • Earning Date
  • MRNA 11-07-2024
  • MRO 11-06-2024
  • Dividend Yield
  • MRNA N/A
  • MRO 1.54%
  • EPS Growth
  • MRNA N/A
  • MRO N/A
  • EPS
  • MRNA N/A
  • MRO 2.32
  • Revenue
  • MRNA $5,081,000,000.00
  • MRO $6,561,000,000.00
  • Revenue This Year
  • MRNA N/A
  • MRO $3.50
  • Revenue Next Year
  • MRNA N/A
  • MRO $0.39
  • P/E Ratio
  • MRNA N/A
  • MRO $12.32
  • Revenue Growth
  • MRNA N/A
  • MRO 1.66
  • 52 Week Low
  • MRNA $35.80
  • MRO $21.81
  • 52 Week High
  • MRNA $170.47
  • MRO $30.06
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 12.62
  • MRO 59.37
  • Support Level
  • MRNA $41.54
  • MRO $27.96
  • Resistance Level
  • MRNA $56.70
  • MRO $28.83
  • Average True Range (ATR)
  • MRNA 2.95
  • MRO 0.60
  • MACD
  • MRNA -1.05
  • MRO 0.16
  • Stochastic Oscillator
  • MRNA 4.80
  • MRO 84.36

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About MRO Marathon Oil Corporation

Marathon is an independent exploration and production company primarily focusing on unconventional resources in the United States. At the end of 2023, the company reported net proved reserves of 1.1 billion barrels of oil equivalent. Net production averaged 405 thousand barrels of oil equivalent per day in 2023 at a ratio of roughly 70% oil and NGLs and 30% natural gas.

Share on Social Networks: